1. Alzheimer's disease as an autoimmune disorder of innate immunity endogenously modulated by tryptophan metabolites. Issue 1 (6th April 2022) Authors: Meier‐Stephenson, Felix S.; Meier‐Stephenson, Vanessa C.; Carter, Michael D.; Meek, Autumn R.; Wang, Yanfei; Pan, Luzhe; Chen, Qiangwei; Jacobo, Sheila; Wu, Fan; Lu, Erhu; Simms, Gordon A.; Fisher, Laural; McGrath, Alaina J.; Fermo, Virgil; Barden, Christopher J.; Clair, Harman D.S.; Galloway, To... Journal: Alzheimer's & dementia Issue: Volume 8:Issue 1(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P2‐044: The Development of High Throughput Screening Strategies to Identify Anti‐Proteopathic and Anti‐Immunopathic Agents for The Treatment of Alzheimer's Dementia. (1st July 2016) Authors: Weaver, Donald F.; Meek, Autumn; Barden, Christopher; Reed, Mark; Taylor, Marcia; Wang, Yanfei; Simms, Gordon A. Journal: Alzheimer's & dementia Issue: Volume 12:Supplement 7S(2016)Part 13 Page Start: P624 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P4‐169: Identification of endogenous β‐amyloid anti‐oligomerization agents via in silico screening of a library of known human cns compounds against the e‐v‐h‐h‐q‐k domain of β‐amyloid. (1st July 2015) Authors: Meek, Autumn; Simms, Gordon A.; Wang, Yanfei; Wu, Fan; Taylor, Marcy; Reed, Mark; Barden, Christopher; Weaver, Donald F. Journal: Alzheimer's & dementia Issue: Volume 11(2015)Supplement 7:Part 18 Page Start: P843 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗